Clinical Trials

A phase III study of TTFields combined with chemotherapy for advanced Non-Small-Cell Lung Cancer of squamous histology. more...

A phase II study of TTFields combined with chemotherapy for mesothelioma. more...

A phase II study of TTFields combined with chemotherapy for recurrent ovarian cancer more...

A phase II study of TTFields combined with chemotherapy for newly-diagnosed pancreatic cancer. more...

A phase II study of TTFields following local therapy for 1-5 Brain Metastases from Non-Small-Cell Lung Cancer. more...

A phase III study of TTFields following Stereotactic Radiosurgery for 1-10 Brain Metastases from Non-Small-Cell Lung Cancer more...

TTFields

TTFields have been approved by FDA for the treatment of adult patients suffering from recurrent glioblastoma.

TTFields is currently being tested for other cancers in various clinical trials, presented in this website. TTFields is experimental for all indications mentioned in those clinical trials and has not been approved for their treatment.